Why the study?
Does a new equation improve the accuracy of LDL-C calculation in patients with normolipidemia and/or hypertriglyceridemia compared to standard methods?
Does a new equation improve the accuracy of LDL-C calculation in patients with normolipidemia and/or hypertriglyceridemia compared to standard methods?
Answers are grounded in this paper and cite their sources.
A new equation improves the accuracy of LDL-C calculation in patients with low LDL-C or hypertriglyceridemia without adding costs to the standard lipid panel, aiding in cardiovascular disease risk management.
The new equation can be readily implemented by clinical laboratories with no additional costs compared with the standard lipid panel. It will allow for more accurate calculation of LDL-C level in patients with low LDL-C levels and/or hypertriglyceridemia (TG levels, ≤800 mg/dL) and thus should improve the use of LDL-C level in cardiovascular disease risk management.
No takes yet. Share an insight, caveat, or question.
Sampson et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: